ORAGEN-C Trademark

Trademark Overview

On Friday, July 21, 2017, a trademark application was filed for ORAGEN-C with the United States Patent and Trademark Office. The USPTO has given the ORAGEN-C trademark a serial number of 79218450. The federal status of this trademark filing is Section 71 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, May 20, 2025. This trademark is owned by Pacific Pharmaceuticals Pte Ltd. The ORAGEN-C trademark is filed in the Pharmaceutical Products category with the following description:

Mineral dietary supplements for humans containing Vitamin C; pharmaceutical drugs, namely, antipyretics, anti-infectives, antineoplastics, diuretics, and pharmaceutical preparations containing Vitamin C for the treatment of immune system disorders, disorders of the central nervous system, endocrine disorders, gastrointestinal diseases, dermatological diseases, infectious diseases, cardiovascular diseases, and respiratory diseases
oragen-c

General Information

Serial Number79218450
Word MarkORAGEN-C
Filing DateFriday, July 21, 2017
Status739 - Section 71 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, May 20, 2025
Registration Number5663319
Registration DateTuesday, January 29, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 13, 2018

Trademark Statements

Goods and ServicesMineral dietary supplements for humans containing Vitamin C; pharmaceutical drugs, namely, antipyretics, anti-infectives, antineoplastics, diuretics, and pharmaceutical preparations containing Vitamin C for the treatment of immune system disorders, disorders of the central nervous system, endocrine disorders, gastrointestinal diseases, dermatological diseases, infectious diseases, cardiovascular diseases, and respiratory diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 18, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePacific Pharmaceuticals Pte Ltd
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressSingapore 069533
SG
Party NamePacific Pharmaceuticals Pte Ltd
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSingapore 069533
SG
Party NamePacific Pharmaceuticals Pte Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSingapore 069533
SG

Trademark Events

Event DateEvent Description
Friday, October 27, 2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, October 12, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB
Wednesday, October 18, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 20, 2017ASSIGNED TO EXAMINER
Monday, October 23, 2017NON-FINAL ACTION WRITTEN
Tuesday, October 24, 2017APPLICATION FILING RECEIPT MAILED
Tuesday, October 24, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, October 27, 2017REFUSAL PROCESSED BY MPU
Friday, October 5, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 24, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 24, 2018NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Friday, November 17, 2017REFUSAL PROCESSED BY IB
Wednesday, February 7, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 7, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 8, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 20, 2018SUSPENSION LETTER WRITTEN
Tuesday, February 20, 2018LETTER OF SUSPENSION E-MAILED
Tuesday, February 20, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, September 18, 2018ASSIGNED TO LIE
Tuesday, September 18, 2018SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, January 29, 2019REGISTERED-PRINCIPAL REGISTER
Monday, April 29, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, October 24, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, November 9, 2018NOTIFICATION PROCESSED BY IB
Tuesday, November 13, 2018PUBLISHED FOR OPPOSITION
Tuesday, November 13, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, May 22, 2019FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, May 22, 2019FINAL DISPOSITION PROCESSED
Tuesday, May 20, 2025REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Tuesday, May 20, 2025NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Monday, May 19, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, June 7, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, January 29, 2024COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Thursday, January 23, 2025TEAS SECTION 71 & 15 RECEIVED

Related Keywords

oragen diseases disorders pharmaceutical vitamin containing system nervous central endocrine dermatological